Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 1.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.35
  • 52 Week Low: 1.10
  • Currency: UK Pounds
  • Shares Issued: 979.75m
  • Volume: 1,430,782
  • Market Cap: 15.68m
  • RiskGrade: 340

HEMO Overview

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

HEMO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (2.41) (0.91)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (1.59) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (1.49) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (2.10) (0.50)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.11) (0.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HEMO Company Announcements

Appointment of Medical Director 10-Aug-2022 07:00 RNS
Second Price Monitoring Extn 09-Aug-2022 14:06 RNS
Price Monitoring Extension 09-Aug-2022 14:00 RNS

Latest HEMO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.35
52 Week Low 1.10
Volume 1,430,782
Shares Issued 979.75m
Market Cap 15.68m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.69% below the market average3.69% below the market average3.69% below the market average3.69% below the market average3.69% below the market average
7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average
Price Trend
45.78% below the market average45.78% below the market average45.78% below the market average45.78% below the market average45.78% below the market average
9.38% above the sector average9.38% above the sector average9.38% above the sector average9.38% above the sector average9.38% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 12-Aug-2022

Time Volume / Share Price
16:16 304 @ 1.64p
16:11 10,000 @ 1.64p
16:06 20,785 @ 1.58p
15:47 3,645 @ 1.64p
15:35 6,729 @ 1.64p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page